Clinical trials in Netherlands
15,224 studies list at least one site in Netherlands. 2,564 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-11-10.
Status
Most studied here
Who runs them
Radboud University Medical Center (899) · Maastricht University Medical Center (805) · University Medical Center Groningen (562) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (492) · Erasmus Medical Center (445) · Novartis Pharmaceuticals (427) · UMC Utrecht (338) · Leiden University Medical Center (307)
What changed recently
From the registry's own updates since Oct 11, 2026.
Started recruiting23
- A Study to Investigate the Efficacy and Safety of Belumosudil Compared With Best Available Therapy in Participants Aged 12 Years or Older With Chronic Graft-versus-host DiseaseNov 6, 2026NCT07771439
- A Study to Evaluate the Metabolism, the Routes and Extent of Elimination, and Drug Levels of [14C]Navlimetostat (BMS-986504) in Healthy Female ParticipantsNov 6, 2026NCT07777133
- STV Analysis Versus Visual Evaluation of Cardiotocography in FGRNov 4, 2026NCT06010238
- Preeclampsia Intervention NetherlandsNov 4, 2026NCT06452498
- Hemodynamic Evaluation and Assessment of DIRECT myocaRdial and Sublingual Capillary Perfusion in Thoracic Surgery Patients on Cardiopulmonary BypassNov 4, 2026NCT07135700
Show 18 moreShow fewer
- A Clinical Trial To Investigate The Effect Of EA-230 On Hospital Length Of Stay In Patients With Coronary Artery Disease (CAD) Undergoing Coronary Artery Bypass Grafting (CABG) Surgery.Nov 2, 2026NCT07357675
- SYMmetric Valve fraME Expansion To Reduce hYpoattenuated Leaflet Thickening After Balloon-expandable TAVI: the SYMMETRY TrialOct 30, 2026NCT07872020
- In-situ vs Ex-situ Liver PreservationOct 30, 2026NCT07899853
- Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)Oct 28, 2026NCT04886804
- Drug Repurposing in Thyroid Carcinoma: a Feasibility TrialOct 28, 2026NCT07485569
- The BALANCE Study: BlAck and Mixed Men's Lived Experience With Prostate cANCEr-Diversity in Prostate Cancer PROMS StudyOct 27, 2026NCT07529418
- International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)Oct 26, 2026NCT07476729
- VATS or Intrapleural Enzymatic Therapy for Patients With Empyema.Oct 26, 2026NCT07886541
- Neoadjuvant FOLFOXIRI and Chemoradiotherapy Versus Neoadjuvant CAPOX/FOLFOX and Chemoradiotherapy Followed by Surgery or a Watch-and-Wait Approach in High Risk Locally Advanced Rectal CancerOct 23, 2026NCT07472868
- Neoadjuvant Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon CancerOct 22, 2026NCT07808151
- Whole Body HER2 Quantification With 89Zr-Trastuzumab PET/CT to Asses Zr-trastuzumab Accumulation in HER2-mutated and HER2-overexpressing Metastatic Non-small Cell Lung CancerOct 20, 2026NCT07436858
- Real-world Evaluation of the Implementation of LC-OCT in Daily Clinical PracticeOct 19, 2026NCT07501780
- Sensorimotor Psychotherapy for Personality DisordersOct 16, 2026NCT07342270
- A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor ResectionOct 13, 2026NCT07128199
- Proof-of-Concept for a Novel Optical Aperture Contact Lens in Presbyopia and KeratoconusOct 13, 2026NCT07559188
- Prospective Evaluation of Flare Detection in IBD With Digital Biomarkers: Bring Your Own Device StudyOct 13, 2026NCT07647640
- Guideline Implementation and Quality of Care Evaluation in Patients With Heart Failure and Reduced Ejection Fraction (HFrEF)Oct 13, 2026NCT07702760
- A Study to Test Obrixtamig in Combination With Pumitamig in People With Advanced Small Cell Lung Cancer (Dareon®-Rosetta35)Oct 13, 2026NCT07843940
First site in Netherlands30
- A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein ExpressionNov 9, 2026NCT07546500
- Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom BurdenNov 9, 2026NCT07621809
- A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's DiseaseNov 9, 2026NCT07737743
- Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )Nov 6, 2026NCT07621718
- A Study to Investigate the Efficacy and Safety of Belumosudil Compared With Best Available Therapy in Participants Aged 12 Years or Older With Chronic Graft-versus-host DiseaseNov 6, 2026NCT07771439
Show 25 moreShow fewer
- Phase 1 Study of PF-08046033 in Advanced Solid TumorsNov 5, 2026NCT07519655
- STV Analysis Versus Visual Evaluation of Cardiotocography in FGRNov 4, 2026NCT06010238
- Preeclampsia Intervention NetherlandsNov 4, 2026NCT06452498
- Hemodynamic Evaluation and Assessment of DIRECT myocaRdial and Sublingual Capillary Perfusion in Thoracic Surgery Patients on Cardiopulmonary BypassNov 4, 2026NCT07135700
- A Study of LY3971297 in Participants With Heart FailureNov 4, 2026NCT07547540
- ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of Empasiprubart IV Monotherapy in Participants With AChR-Ab Seropositive Generalized Myasthenia GravisNov 4, 2026NCT07673627
- Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)Nov 3, 2026NCT07224360
- Study to Assess the Efficacy and Safety of Rina-S in Participants With Advanced Gastrointestinal (GI) CancersNov 3, 2026NCT07539311
- Lead Evaluation for Defibrillation and Reliability Post Approval StudyNov 2, 2026NCT07005232
- Visugromab in Cachexia International TrialNov 2, 2026NCT07112196
- Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast CancerOct 29, 2026NCT07604571
- The BALANCE Study: BlAck and Mixed Men's Lived Experience With Prostate cANCEr-Diversity in Prostate Cancer PROMS StudyOct 27, 2026NCT07529418
- VATS or Intrapleural Enzymatic Therapy for Patients With Empyema.Oct 26, 2026NCT07886541
- An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative ColitisOct 23, 2026NCT07184996
- Real-World Data Collection of GORE Devices Used In the Endovascular Treatment of Aortic Aneurysms Which Incorporate Visceral Arteries.Oct 23, 2026NCT07480395
- A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's DiseaseOct 21, 2026NCT07184944
- Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel DiseaseOct 20, 2026NCT05701358
- AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)Oct 19, 2026NCT07611110
- PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients (PRIMALung Study)Oct 16, 2026NCT04790253
- A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative ColitisOct 16, 2026NCT07185009
- Sensorimotor Psychotherapy for Personality DisordersOct 16, 2026NCT07342270
- A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)Oct 14, 2026NCT06908226
- Phase 3 Trial of Reltodecacog Alfa (VMX-C001) vs Usual Pharmacological Care in Patients Taking a FXa Direct Oral Anticoagulant Who Require Urgent Surgery With or Without Heparin.Oct 14, 2026NCT07288489
- Guideline Implementation and Quality of Care Evaluation in Patients With Heart Failure and Reduced Ejection Fraction (HFrEF)Oct 13, 2026NCT07702760
- Skin Type Determination Using Image Artificial IntelligenceOct 13, 2026NCT07765303
Results posted26
- A Study of Lebrikizumab (RO5490255) in Participants With Severe Oral Corticosteroids (OCS) Dependent AsthmaNov 10, 2026NCT01987492
- Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPCNov 10, 2026NCT03792841
- A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung CancerNov 9, 2026NCT04294810
- A Study in Healthy Men to Test How BI 1291583 is Taken up by the BodyNov 9, 2026NCT06166992
- A Study of JNJ-63733657 in Participants With Early Alzheimer's DiseaseNov 5, 2026NCT04619420
Show 21 moreShow fewer
- A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS)Nov 5, 2026NCT04968912
- Ravulizumab in Thrombotic Microangiopathy After Hematopoietic Stem Cell TransplantNov 4, 2026NCT04543591
- Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy PatientsNov 4, 2026NCT04578834
- An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care (SoC), Versus SoC Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)Nov 4, 2026NCT04720157
- Lead EvaluAtion for Defibrillation and Reliability (LEADR) / Lead Evaluation for Defibrillation and Reliability in Left Bundle Branch Area Pacing (LEADR LBBAP)Nov 4, 2026NCT04863664
- A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)Nov 3, 2026NCT04628494
- Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 DiabetesNov 2, 2026NCT04916470
- Tiotropium/Salmeterol Inhalation Powder (Spiriva Handihaler and Salmeterol Polyethylene (PE) Capsule) in Chronic Obstructive Pulmonary Disease (COPD)Oct 29, 2026NCT00662740
- ARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKEOct 29, 2026NCT05746559
- Effects of Maintenance Cabozantinib+BSC Versus BSC in Children and AYA With OsteosarcomaOct 29, 2026NCT06341712
- An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMDOct 28, 2026NCT04770545
- A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary DiseaseOct 28, 2026NCT05595642
- A Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2Oct 27, 2026NCT05737940
- SELUTION SLR™ 014 In-stent RestenosisOct 20, 2026NCT04280029
- A Study of Rusfertide in Adults With Polycythemia Vera (PV)Oct 19, 2026NCT05210790
- A Study to Evaluate the Efficacy and Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary DiseaseOct 16, 2026NCT05037929
- Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary FibrosisOct 15, 2026NCT05255991
- Evaluation of Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) in Cystic Fibrosis (CF) Participants 12 to Less Than 24 Months of AgeOct 15, 2026NCT05882357
- A Study of Adeno-Associated Virus Serotype 8-Mediated Gene Transfer of Glucose-6-Phosphatase in Patients With Glycogen Storage Disease Type Ia (GSDIa)Oct 14, 2026NCT05139316
- Cryoablation for Monomorphic Ventricular Tachycardia (CryoCure-VT)Oct 13, 2026NCT04893317
- Luveltamab Tazevibulin (STRO-002) in Infants and Children < 12 Years of Age With Relapsed/Refractory CBFA2T3::GLIS2 AMLOct 13, 2026NCT06679582
Stopped10
- A Study of Lebrikizumab (RO5490255) in Participants With Severe Oral Corticosteroids (OCS) Dependent AsthmaTerminatedNov 10, 2026NCT01987492
- Chronic Fatigue in the Internal Medicine Outpatient Clinic: a Mixed-methods Quantitative and Qualitative StudyTerminatedOct 30, 2026NCT06775262
- Physical Exercise Prehabilitation Program in mEtabolic suRgeryTerminatedOct 30, 2026NCT06889207
- A Study Evaluating the Efficacy of Xanomeline/Trospium (XT) on Cognitive Impairment After 24 and 52 Weeks of Treatment in Adult Participants With SchizophreniaWithdrawnOct 30, 2026NCT07084831
- Metabolic Heterogeneity Underlying Hypertriglyceridemia: Hepatic Triglyceride Biosynthesis in Humans With Different Insulin Resistance PhenotypesTerminatedOct 27, 2026NCT05743868
Show 5 moreShow fewer
- Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in CombinationTerminatedOct 26, 2026NCT04868877
- A Study of MK-1484 as Monotherapy and in Combination With Pembrolizumab (MK-3475) In Advanced or Metastatic Solid Tumors (MK-1484-001)TerminatedOct 21, 2026NCT05382325
- Baroloop Multicenter Trial (Baroloop MCT)TerminatedOct 20, 2026NCT06518915
- Trastuzumab + Alpelisib +/- Fulvestrant vs Trastuzumab + CT in PIK3CA-mutated HER2+ Advanced BC (ALPHABET)TerminatedOct 15, 2026NCT05063786
- A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.TerminatedOct 13, 2026NCT06637631
Newly registered31
- A Study of Brenipatide in Participants With Major Depressive DisorderNov 10, 2026NCT07928245
- Milk IntraNasal Therapy in Infants With Posthemorrhagic Ventricular Dilatation: A Safety and Feasibility StudyNov 10, 2026NCT07928271
- Neoadjuvant Trastuzumab, Pertuzumab and Zongertinib Without Chemotherapy in HER2-positive Breast Cancer: the TRAIN-5 StudyNov 10, 2026NCT07928479
- Safety and Effectiveness Assessment of AneuFix Injectable Polymer Sac Filling to Assure Long-term Durability of EVAR.Nov 10, 2026NCT07928505
- The Impact of Incretins on Fat-free Mass, Muscle Strength and Functional CapacityNov 10, 2026NCT07929831
Show 26 moreShow fewer
- AI-Based Tools for Stroke Diagnosis, Treatment and Outcome Prediction: a Multicentre Prospective Observational StudyNov 9, 2026NCT07924371
- A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and ObesityNov 5, 2026NCT07919405
- A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)Nov 4, 2026NCT07915219
- Continuous Noninvasive Multimodal Neuromonitoring at the ICU After Cardiac ArrestNov 3, 2026NCT07912411
- Multi-biomarkers in DEENov 2, 2026NCT07909382
- Cross-cultural Adaptation and Validation of the Localised Scleroderma Quality of Life Instrument (LoSQI) in Juvenile Localised Scleroderma (JLS)Oct 30, 2026NCT07908108
- Trauma-Related Attributions in Trauma Treatment: An Observational StudyOct 30, 2026NCT07908186
- Assessment of the Value of FAPI and FDG-PET-CT in Diagnosis of Acute Phase Peyronie's DiseaseOct 29, 2026NCT07903987
- The REVIVE-PEEP Trial: Positive End-expiratory Pressure Versus Sham Valve/Zero End-expiratory Pressure in Cardiopulmonary Resuscitation During Manual Ventilation to Improve Neurological Outcomes at Discharge in Adult Patients Suffering an Out-of-hospital Cardiac ArrestOct 29, 2026NCT07905482
- A Retrospective Cohort Study Evaluating Major Adverse Cardiovascular Events and Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease Without Prior Ischemic Events (OPTIMUS RISK - Netherlands)Oct 29, 2026NCT07905508
- In-situ vs Ex-situ Liver PreservationOct 28, 2026NCT07899853
- The Effect of Theory-driven Physiotherapy on Physical Activity in Knee OA.Oct 28, 2026NCT07901881
- Overcoming Immunotherapy Resistance in Hepatocellular CarcinomaOct 26, 2026NCT07895342
- The CORE Platform TrialOct 23, 2026NCT07892976
- Feasibility of Physical Prehabilitation for High-Risk Patients Undergoing Cardiac Surgery Via SternotomyOct 23, 2026NCT07893184
- VATS or Intrapleural Enzymatic Therapy for Patients With Empyema.Oct 21, 2026NCT07886541
- AI-based Algorithm Development for Improved Diagnostics in the Intensive Care and Acute Stroke Setting Using ElectroencephalographyOct 21, 2026NCT07886957
- Flap Assessment With Regional Oximetry for Early Detection of Compromise in Free Flap Reconstructive Surgery - FLARE StudyOct 21, 2026NCT07887256
- Study With Batten-1 (Miglustat Liquid Formulation) to Treat Ceroid Lipofuscinosis Neuronal 3 (CLN3) DiseaseOct 20, 2026NCT07882290
- Prehospital Transfusion Outcomes in Traumatic Hemorrhage: a Prospective Cohort StudyOct 20, 2026NCT07883252
- AI Analysis of CT Scans to Classify Ovarian Tumours as Benign, Borderline or Malignant Before SurgeryOct 20, 2026NCT07883551
- A Multiple-dose Study Investigating the Drug-drug Interaction Potential and QTc Effects of Fosmanogepix in Healthy Adult SubjectsOct 19, 2026NCT07881224
- A Study of BMS-986553 in Participants With Refractory Autoimmune DiseasesOct 14, 2026NCT07873931
- The OXY-VENT StudyOct 13, 2026NCT07870551
- Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to RelapseOct 13, 2026NCT07871864
- SYMmetric Valve fraME Expansion To Reduce hYpoattenuated Leaflet Thickening After Balloon-expandable TAVI: the SYMMETRY TrialOct 13, 2026NCT07872020
Studies
Recruiting first, then most recently updated. Showing 50 of 15,224 — search for more.
- Milk IntraNasal Therapy in Infants With Posthemorrhagic Ventricular Dilatation: A Safety and Feasibility StudyEnrolling by invitationNCT07928271Phase 1/2
- A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).RecruitingNCT06646276Phase 3
- Alert-HF: Early Detection and Intervention on Atrial Fibrillation in Heart Failure PatientsNot yet recruitingNCT07816458Not applicable
- Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)RecruitingNCT03486873Phase 3
- Safety and Effectiveness Assessment of AneuFix Injectable Polymer Sac Filling to Assure Long-term Durability of EVAR.Not yet recruitingNCT07928505Not applicable
- LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLCRecruitingNCT06216301Phase 3
- A Study of Brenipatide in Participants With Major Depressive DisorderNot yet recruitingNCT07928245Phase 2
- A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)RecruitingNCT06430801Phase 3
- Neoadjuvant Trastuzumab, Pertuzumab and Zongertinib Without Chemotherapy in HER2-positive Breast Cancer: the TRAIN-5 StudyNot yet recruitingNCT07928479Phase 1
- A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)RecruitingNCT06345729Phase 3
- A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe AsthmaRecruitingNCT06023589Phase 3
- Careful Ventilation in Acute Respiratory Distress Syndrome (COVID-19 and Non-COVID-19)RecruitingNCT03963622Not applicable
- A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine CancerRecruitingNCT06340568Phase 3
- Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)RecruitingNCT04924075Phase 2
- Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 AlterationsRecruitingNCT06581432Phase 2
- Dabrafenib and/or Trametinib Rollover StudyRecruitingNCT03340506Phase 4
- VT Ablation in the iCMRRecruitingNCT05543798Not applicable
- A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)RecruitingNCT06841354Phase 3
- A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced CoagulopathyRecruitingNCT06854640Phase 1
- A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)RecruitingNCT06717347Phase 3
- A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)RecruitingNCT06952504Phase 3
- A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)RecruitingNCT06818643Phase 1/2
- A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)RecruitingNCT06312137Phase 3
- Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)RecruitingNCT05714085Phase 2/3
- EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)RecruitingNCT06997588Phase 2
- The Effect of Repeated Whole-body NMES Sessions With or Without Protein Intake on Muscle Protein Synthesis During 3 Days of Bed Rest in Healthy Young VolunteersRecruitingNCT07062562Not applicable
- Immunoadsorption in Autoimmune Long COVIDRecruitingNCT07316127Phase 2
- Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued TreatmentRecruitingNCT07444567Phase 3
- Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued TreatmentRecruitingNCT07691970Phase 3
- A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart Zotadirsen) in Participants With DMD With Gene Mutations Amenable to Exon 44 SkippingRecruitingNCT07587242Phase 3
- DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard ChemoimmunotherapyRecruitingNCT07472517Phase 3
- A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)RecruitingNCT07357727Phase 3
- DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard ChemotherapyRecruitingNCT07544654Phase 3
- A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)RecruitingNCT07222488Phase 1/2
- A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)RecruitingNCT07190248Phase 3
- A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)RecruitingNCT07159841Phase 2/3
- A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps Children and Adolescents With Interstitial Lung Disease (FIBRONEER-chILD)RecruitingNCT07366034Phase 3
- A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)RecruitingNCT07489495Phase 3
- KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)RecruitingNCT07252739Phase 2
- A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)RecruitingNCT07570173Phase 2/3
- A Study to Evaluate Atumelnant in Adults With Congenital Adrenal HyperplasiaRecruitingNCT07144163Phase 3
- Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CPRecruitingNCT07354074Phase 2
- A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)RecruitingNCT07276724Phase 3
- A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)RecruitingNCT07554339Phase 3
- A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)RecruitingNCT07058077Phase 2/3
- A Study of Orelabrutinib in Patients With Primary Progressive Multiple SclerosisRecruitingNCT07067463Phase 3
- A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)RecruitingNCT07419295Phase 3
- A Study to Test Obrixtamig in Combination With Pumitamig in People With Advanced Small Cell Lung Cancer (Dareon®-Rosetta35)RecruitingNCT07843940Phase 1/2
- VATS or Intrapleural Enzymatic Therapy for Patients With Empyema.RecruitingNCT07886541Phase 4
- The Impact of Incretins on Fat-free Mass, Muscle Strength and Functional CapacityRecruitingNCT07929831